Chemical formula: C₂₈H₄₂Cl₂N₄O₂+₂  Molecular mass: 537.565 g/mol  PubChem compound: 2131

Active ingredient description

Ambenonium (as ambenonium dichloride) is a cholinesterase inhibitor used in the management of myasthenia gravis. Ambenonium exerts its actions against myasthenia gravis by competitive reversible inhibition of acetylcholinesterase, the enzyme responsible for the hydrolysis of acetylcholine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N07AA30 Ambenonium N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA30

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 115-79-7
CAS Substance: 7648-98-8
DrugBank Drug: DB01122
PubChem Compound: 2131
RxNorm Ingredient: 623
SNOMED-CT Concept: 387197009
Ambenonium (substance)
UNII Identifier: L16PUN799N


Ambenonium is an active ingredient of these brands:

France (FR)

Japan (JP)

Poland (PL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.